- 全部删除
- 您的购物车当前为空
K783-0308 是有效的、选择性的MNK2和FLT3的双重抑制剂,IC50值分别为 406 和 680nM。 K783-0308 促进急性髓性白血病 (AML)的 细胞凋亡和细胞周期停滞在 G0/G1 期。K783-0308 抑制 MV-4-11 和 MOLM-13 细胞生长,IC50 值分别为 10.4 和 10.5 μM
K783-0308 是有效的、选择性的MNK2和FLT3的双重抑制剂,IC50值分别为 406 和 680nM。 K783-0308 促进急性髓性白血病 (AML)的 细胞凋亡和细胞周期停滞在 G0/G1 期。K783-0308 抑制 MV-4-11 和 MOLM-13 细胞生长,IC50 值分别为 10.4 和 10.5 μM
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 10,600 | 6-8周 | |
50 mg | ¥ 13,800 | 6-8周 | |
100 mg | ¥ 17,500 | 6-8周 |
K783-0308 相关产品
产品描述 | K783-0308 is a potent and selective MNK2 and FLT3 dual inhibitor with IC 50 values of 406 and 680 nM, respectively. K783-0308 promotes the apoptosis and cell cycle arrests in the G0/G1 phase of acute myeloid leukemia (AML) cell. K783-0308 inhibits the MV-4-11 and MOLM-13 cell growth with IC50 values of 10.4 and 10.5 μM, respectively [1]. |
靶点活性 | MNK2:406 nM |
体外活性 | K783-0308 (MOLM-13, MV-4-11 cells) shows cytotoxic effect against MOLM-13 (IC 50 =10.5 μM) and MV-4-11 (IC 50 =10.4 μM) cells [1]. K783-0308 (1, 3, 10, 30 μM) promotes AML cell apoptosis and cell cycle arrests in the G0/G1 phase [1]. Cell Cytotoxicity Assay [1] Cell Line: MOLM-13, MV-4-11 cells (RPMI-1640 supplemented with streptomycin (100 μg/mL)/penicillin (100 U/mL)/ amphotericin B (0.25 μg/mL)) Concentration: 1, 3, 10, 30 μM Incubation Time: 48 h, 72 h Result: Promotes AML cell apoptosis and cell cycle arrested in the G0/G1 phase. |
分子量 | 333.43 |
分子式 | C21H23N3O |
CAS No. | 422554-29-8 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容